These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 98800)

  • 1. Amphetamine- type reinforcement by dopaminergic agonists in the rat.
    Yokel RA; Wise RA
    Psychopharmacology (Berl); 1978 Jul; 58(3):289-96. PubMed ID: 98800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of piribedil (ET495) on components of locomotor activity.
    Jenner P; Marsden CD
    Eur J Pharmacol; 1975 Aug; 33(1):211-5. PubMed ID: 1175688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine.
    Herberg LJ; Stephens DN; Franklin KB
    Pharmacol Biochem Behav; 1976 May; 4(5):575-82. PubMed ID: 133356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dopaminergic systems in gamma-hydroxybutyrate-induced electrocorticogram hypersynchronization in the rat.
    Godschalk M; Dzoljic MR; Bonta IL
    J Pharm Pharmacol; 1977 Oct; 29(10):605-8. PubMed ID: 21239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine discrimination as a test for anti-parkinsonism drugs.
    Schechter MD
    Eur J Pharmacol; 1977 Jul; 44(1):51-6. PubMed ID: 885158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral interactions between naloxone and dopamine agonists.
    Harris RA; Snell D; Loh HH; Way EL
    Eur J Pharmacol; 1977 Jun; 43(3):243-6. PubMed ID: 872878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine.
    Ladinsky H; Consolo S; Bianchi S; Samanin R; Ghezzi D
    Brain Res; 1975 Feb; 84(2):221-6. PubMed ID: 1111831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
    Horowski R; Gräf HJ
    Neuroendocrinology; 1976; 22(3):273-86. PubMed ID: 1028957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.
    Burns LH; Everitt BJ; Kelley AE; Robbins TW
    Psychopharmacology (Berl); 1994 Aug; 115(4):516-28. PubMed ID: 7871097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
    Buckett WR; Shaw JS
    Psychopharmacologia; 1975 Jun; 42(3):293-7. PubMed ID: 1172254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical regulation of feeding in the rat: facilitation by alpha-noradrenergic, but not dopaminergic, receptor stimulants.
    Ritter S; Wise D; Stein L
    J Comp Physiol Psychol; 1975 Feb; 88(2):778-84. PubMed ID: 239031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of effects of dopaminergic agonists on neuronal activity in the caudate-putamen of the rat following long-term d-amphetamine administration.
    Rebec GV; Groves PM
    Pharmacol Biochem Behav; 1976 Sep; 5(3):349-57. PubMed ID: 996066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopamine agonists and fenfluramine on discriminative behavior in obese and lean Zucker rats.
    Schechter MD; Finkelstein JA
    Pharmacol Biochem Behav; 1985 Jul; 23(1):7-11. PubMed ID: 4034621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of noradrenergic and dopaminergic processes in amphetamine self-administration.
    Risner M; Jones BE
    Pharmacol Biochem Behav; 1976 Oct; 5(4):477-82. PubMed ID: 1005495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
    van der Elst MC; Wunderink YS; Ellenbroek BA; Cools AR
    Psychopharmacology (Berl); 2007 Jan; 190(1):93-102. PubMed ID: 17031706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of piribedil on schedule-controlled responding of the pigeon.
    Leander JD
    Pharmacol Biochem Behav; 1982 Nov; 17(5):995-1000. PubMed ID: 7178209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of dopaminergic agonists on food-reinforced operant behavior in the long-tailed macaque (Macaca fascicularis).
    Dooley DJ; Bowden DM
    Psychopharmacology (Berl); 1983; 81(2):170-6. PubMed ID: 6415750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigral dopaminergic neurons: differential sensitivity to apomorphine following long-term treatment with low and high doses of amphetamine.
    Kamata K; Rebec GV
    Brain Res; 1984 Oct; 321(1):147-50. PubMed ID: 6498510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.